Texas Instruments: margins and cash flow turn as the investment cycle winds down

Texas Instruments' third quarter was the clearest sign yet that its long, expensive build-out is paying off. Growth, profitability and cash generation all stepped up at the same time, and the spending that held back free cash flow for years is now falling away.

• Revenue was $6.06 billion, up 28% from a year earlier and 11% from the previous quarter [2]. TI describes "broad demand, with revenue growth across all end markets and regions" [1], and "continued broad growth in industrial, automotive and data center" [2].
• Gross margin rose to 64.2% of revenue from 57.4% a year earlier [1].
• Operating profit was $2.87 billion, or 47.5% of revenue, compared with $1.66 billion, or 35.1% [1]. Earnings per share were $2.62 against $1.48 [1].
• Capital spending fell to $463 million in the quarter from $1,197 million a year earlier [2]. Over the first nine months it was $1.65 billion against $3.63 billion [1].
• Free cash flow over the past twelve months reached $8.4 billion, or 40.6% of revenue, compared with $2.4 billion and 14.0% a year earlier [2]. (Free cash flow is a non-GAAP measure, as TI defines it.)

The largest segment did most of the work: Analog revenue rose 32% to $4,911 million, and Embedded Processing rose 21% to $858 million [2].

The improvement is not confined to one business. Every segment's operating margin rose from a year earlier, and the smallest one rose the most.

Part of the gain is not operational at all. TI records its CHIPS Act incentives as lower depreciation, and that benefit has grown each year.

A year ago TI was paying out more in dividends than it generated in free cash flow. Now free cash flow covers the dividend with room to spare, while buybacks have nearly stopped ahead of the Silicon Labs payment.

Things in the filings that do not fit the simple story, or that change how the headline numbers should be read.

More of each sales dollar now reaches profit. Over the past twelve months TI spent $4.0 billion on research, development, selling and administration [1], little changed from $3.9 billion in the twelve months to September 2025 [10], while quarterly revenue grew by more than a quarter. With costs roughly flat, higher sales flow straight through to operating margin.

The heavy investment phase is ending. A year ago TI said it was "now mostly through a six-year elevated capital expenditures cycle" [10], and it expects $2 billion to $3 billion of capital spending in 2026 [7] [3], well below the $4.55 billion it spent in 2025 [7]. Lower spending, on top of higher operating cash flow, is why free cash flow has risen so quickly.

The balance sheet is building cash. Cash and short-term investments were $8.14 billion at the end of the quarter, up $3.26 billion since the end of 2025 [1]. TI raised its quarterly dividend by 7% to $1.52 per share [1], while share repurchases slowed sharply: $48 million in the quarter and $636 million over twelve months, against $1,611 million a year earlier [2].

The same filings support two different stories. We set out both; this is not a view on whether to buy or sell the stock.

Testable statements, each with what would support or contradict it and when the next evidence arrives. Thresholds marked "our marker" are ours, not TI's.

• A large acquisition is pending. TI agreed to buy Silicon Labs for $231 per share in cash, an enterprise value of about $7.5 billion [7], with closing expected in the first half of 2027, subject to approvals [3]. In June 2026 it arranged a 364-day term loan of up to $5 billion for the deal [1]. Total debt was $13,650 million at quarter end [1]. The acquisition will change the cash picture, and integrating it is a separate execution risk.
• China is a large exposure. Customers headquartered in China accounted for about 20% of TI's 2025 revenue, and products shipped into China for about 50% [7]. Revenue TI attributes to China was 23% of the total this quarter, up from 21% [1]. New trade restrictions would hit a large part of the business.
• Part of the jump is an easy comparison. A year ago, gross profit growth was "partially offset by higher manufacturing costs associated with our planned capacity expansions" [10]. Some of today's margin gain is recovery from that depressed base, not new strength.
• Growth may pause next quarter. TI's fourth-quarter outlook is revenue of $5.80 billion to $6.30 billion [2]. The midpoint, $6.05 billion (calculated), is about level with the third quarter.
• Semiconductors are cyclical. TI itself warns that inaccurate manufacturing forecasts could leave it holding "inadequate, excess or obsolete inventory that would reduce our profit margins" [7].

• Fourth-quarter 2026 revenue below the $5.80 billion low end of TI's own outlook [2].
• Operating margin falling back below 40%, which would suggest the margin gain was mostly cyclical (our marker, not a TI figure).
• A return to heavier capital spending above TI's $2 billion to $3 billion range for 2026, or a new expansion cycle.
• Silicon Labs closing with materially more debt and no matching rise in cash generation.
• New trade restrictions affecting shipments into China.

TI's fourth-quarter 2026 results and its 2026 annual report. Last year's fourth-quarter results were released on January 27, 2026 [8], so the next update is likely in late January 2027.

Every figure comes from TI's own filings with the SEC, listed below; no market prices or third-party data were used. The statements were extracted from the filings with the help of an AI model, and each quoted passage was checked character for character against the stored filing text. Figures marked "calculated" are simple arithmetic on TI's reported numbers.

Revised October 24, 2026: added the key numbers, the segment, incentive and cash charts, the anomalies, the two readings and the short-, medium- and long-term hypotheses. The new material uses the same filings; no earlier figure or conclusion was changed.